You are here

P&T® Journal contents for April 2003

Features

Letter to the Editor
The Patient Safety and Quality Improvement Act (H.R.663) encourages providers to conduct research and gather data about the causes of medical mishaps and then share their findings with other providers.
Cheryl Servais
The author reviews adalimumab for rheumatoid arthritis, alefacept for psoriasis, and cyclosporine ophthalmic emulsion for chronic dry eye disease.
Marvin M. Goldenberg, PhD, RPh, MS
Physician Perspective
A practicing physician describes the fears that surgeons must confront when treating high-risk patients.
Thomas Marzili, MD
Continuing Education Credit
The author reviews a new medication for the treatment of invasive aspergillosis, febrile neutropenia, and candidiasis.
S. Scott Sutton, PharmD

Departments

Editorial
Editor-in-Chief David Nash, MD, MBA, highlights a company that helps employees resolve problems with their health benefits.
David B. Nash, MD, MBA
Spotlight
Dr. Nancy Greengold is the newest addition to P&T’s Editorial Board.
Sonja Sherritze
Medication Errors
Matthew Grissinger discusses the “rule of 6” shortcut and its tendency to lead to errors.
Matthew Grissinger
Prescription Washington
Stephen Barlas describes the confusion surrounding President Bush’s proposed Medicare drug benefit.
Stephen Barlas
Drug News
The latest information about approvals, indication changes, industry updates, and news from the FDA
Drug Forecast
Dr. Vanni and Mr. Inzerillo review aripiprazole, a new antipsychotic medication.
Nicholas Vanni, PharmD, and Michael T. Inzerillo, MBA